Metraipolis › archive › dc_be7cdc7e42f2

First Report of Entrectinib as a Treatment Option for Pure Squamous Cell Carcinoma Harboring ROS1 Rearrangement: Exploring the Role of Next-Generation… — Europe PMC PMID:41515905

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41515905
DOI
10.3390/ijms27010025
License (as archived)
solo-consultazione
Archived
2026-11-07T12:27:02.708Z
SHA-256 of the archived text
a53a0b3338870cc3e2b2d2b2a0a69b70d78dbdec4b84e6ac8c75bd85dd32af05
Stable URL of this page
https://metraipolis.com/documento/dc_be7cdc7e42f2

How to cite

First Report of Entrectinib as a Treatment Option for Pure Squamous Cell Carcinoma Harboring ROS1 Rearrangement: Exploring the Role of Next-Generation… — Europe PMC PMID:41515905 — Europe PMC (en), https://europepmc.org/article/MED/41515905 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be7cdc7e42f2 (Metraipolis archive dc_be7cdc7e42f2, sha256 a53a0b3338870cc3e2b2d2b2a0a69b70d78dbdec4b84e6ac8c75bd85dd32af05)
BibTeX
@misc{dcbe7cdc7e42f2,
  title = {First Report of Entrectinib as a Treatment Option for Pure Squamous Cell Carcinoma Harboring ROS1 Rearrangement: Exploring the Role of Next-Generation… — Europe PMC PMID:41515905},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41515905},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be7cdc7e42f2; sha256 a53a0b3338870cc3e2b2d2b2a0a69b70d78dbdec4b84e6ac8c75bd85dd32af05},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41515905. Agents can read the archived copy with the MCP tool read_document.